Calbioreagents

Illumina Inc, based in Foster City, CA, is a leading company specializing in next-generation sequencing (NGS) technologies that empower laboratories with advanced instruments, kits, and reagents to conduct genomic research and clinical applications. The company's innovative products, such as the MiSeq i100 series and NovaSeq X, enable researchers to access NGS with exceptional ease and speed, ultimately facilitating significant biological discoveries. In addition to its cutting-edge sequencing platforms, Illumina provides a comprehensive suite of software and analysis services, along with training and support to ensure successful integration into research workflows. Their commitment to innovation extends across various fields, including cancer research, microbiology, and genetic disease studies, positioning Illumina as a pivotal resource in the genomics landscape. Generated from the website

Applikon Inc, operating as Applikon Biotechnology in San Mateo, CA, is a leading provider of online process analyzers and bioreactor systems for research and production purposes. As a subsidiary of Applikon Dependable Instruments in the Netherlands, the company has established collaborations with academic institutes to leverage expertise in bioprocess development. Specializing in various engineering disciplines and software development, Applikon Biotechnology holds ISO 9001:2000 certification, ensuring high-quality standards in its products and services. With a focus on fermentation and cell culture technologies, the company is committed to innovation and automation processes in the biotechnology industry. Generated from their available business information

Dren Bio Inc. is a biotechnology company based in Foster City, California, focused on developing innovative technologies and therapies for patients. The company is dedicated to advancing its pipeline to deliver effective solutions that improve health outcomes. With a leadership team committed to scientific excellence, Dren Bio drives research and development initiatives aimed at addressing unmet medical needs. Their mission reflects a strong commitment to enhancing patient care through groundbreaking advancements in biotechnology. Generated from the website